🇺🇸 FDA
Pipeline program

PF-08634404, YERVOY 5 mg/ml concentrate for solution for infusion

C6461013

Phase 2 small_molecule active

Quick answer

PF-08634404, YERVOY 5 mg/ml concentrate for solution for infusion for Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma is a Phase 2 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials